Sign In
Get Clay Free →

Suggestions

    Robert DeHaven

    Retired Sr. Molecular Pharmacologist; Contract Specialist in Innovation Management at Thomas Jefferson University

    Robert DeHaven is a dedicated Senior Molecular Pharmacologist with a strong commitment to driving basic research towards successful drug discovery projects.

    During his time at Adolor Corporation, Robert excelled as the head of molecular pharmacology, leading a department with a budget of around $1 million.

    His expertise lies in high-throughput screening, assay development, and GPCR pharmacology, being a particularly published expert in this field.

    With a background spanning from large pharmaceutical companies to start-up biotechnology firms, Robert has made significant contributions in therapeutic areas like pain, asthma, inflammation, cancer, and gastrointestinal transit.

    His educational background includes a focus on Biology at West Virginia University.

    Throughout his career, Robert DeHaven has held key roles at institutions such as Thomas Jefferson University, Adolor Corporation, Sterling Winthrop Pharmaceuticals, Merck, and Johns Hopkins School of Medicine.

    Robert DeHaven
    Add to my network

    Location

    Lansdale, Pennsylvania, United States